Lyngby, Denmark

Frank Olsen

This inventor holds 1 USPTO granted patent. Top assignee: Novo Industri A/s. Active years: 1986.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Olsen: Innovator in Enzyme Technology

Introduction

Frank Olsen is a notable inventor based in Lyngby, Denmark. He has made significant contributions to the field of enzyme technology, particularly through his innovative work on alpha-acetolactate decarboxylase enzymes. His research has implications for various applications in biotechnology and industrial processes.

Latest Patents

Frank Olsen holds a patent for a novel alpha-acetolactate decarboxylase enzyme product with improved stability. This enzyme is produced in high levels by cultivating specific Bacillus strains, including Bacillus brevis and Bacillus licheniformis. The patent highlights the potential for enhanced performance in various applications due to the enzyme's stability.

Career Highlights

Olsen's career is marked by his dedication to advancing enzyme technology. His work at Novo Industri A/S has positioned him as a key figure in the development of innovative biotechnological solutions. His expertise in enzyme production and stability has garnered attention in the scientific community.

Collaborations

Frank Olsen collaborates with Knud Aunstrup, contributing to the advancement of their shared research interests. Their partnership exemplifies the collaborative spirit often found in scientific research, leading to innovative breakthroughs.

Conclusion

Frank Olsen's contributions to enzyme technology through his patent and collaborative efforts underscore his role as an influential inventor in the field. His work continues to pave the way for advancements in biotechnology and industrial applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…